Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 23, 2008

Invitrogen Initiates Stem Cell Culture Service

  • Invitrogen introduced its PD-Direct® Bioprocess Services optimized for clinically compliant stem cell culture systems. It will help stem cell therapy developers reduce risks through serum-free production systems, improve manufacturing productivity, and provide on-demand expertise in stem cell media development, according to the firm.

    The science of each stem cell type is different and complex, and off-the-shelf products may not enable therapeutic developers to achieve their goals without significant additional investment, Invitrogen points out.

    PD-Direct® stem cell culture services provide identification of substrates and enzymes that support cell growth and passaging, determination of cell nutritional and supplementation needs, optimization of complete media formulations for key performance and cell characteristics, IP management strategies, design of formulations for clinical compliance and supply chain risk mitigation, as well as transfer to GMP formulation and manufacturing.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »